{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T12:09:45Z","timestamp":1792498185557,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","europeanneuropsychopharmacology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.euroneuro.2015.04.003","type":"journal-article","created":{"date-parts":[[2015,5,2]],"date-time":"2015-05-02T22:36:56Z","timestamp":1430606216000},"page":"1158-1166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"title":["Treatment adherence in schizophrenia: A patient-level meta-analysis of combined CATIE and EUFEST studies"],"prefix":"10.1016","volume":"25","author":[{"given":"P\u00e1l","family":"Czobor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Van Dorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Citrome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene S.","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Wolfgang","family":"Fleischhacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Volavka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2015.04.003_bib1","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1176\/ajp.150.6.873","article-title":"Assessment of insight in psychosis","volume":"150","author":"Amador","year":"1993","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.04.003_bib2","doi-asserted-by":"crossref","first-page":"453","DOI":"10.4088\/JCP.v67n0317","article-title":"Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care","volume":"67","author":"Ascher-Svanum","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.04.003_bib3","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.4088\/JCP.v67n0715","article-title":"A prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophrenia","volume":"67","author":"Ascher-Svanum","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.04.003_bib4","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia","volume":"154","author":"Barnes","year":"1989","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.04.003_bib5","article-title":"Improving Treatment Adherence in Your Patients with Schizophrenia: the STAY Initiative","author":"Canas","year":"2013","journal-title":"Clin. Drug Investig"},{"key":"10.1016\/j.euroneuro.2015.04.003_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/NMD.0000000000000068","article-title":"Medication adherence, knowledge about psychosis, and insight among patients with a schizophrenia-spectrum disorder","volume":"202","author":"Chan","year":"2014","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.euroneuro.2015.04.003_bib7","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1034\/j.1600-0447.2002.02437.x","article-title":"Medication adherence of individuals with a first episode of psychosis","volume":"106","author":"Coldham","year":"2002","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2015.04.003_bib8","doi-asserted-by":"crossref","first-page":"818","DOI":"10.4088\/JCP.v68n0601","article-title":"Adherence to atypical antipsychotic treatment among newly treated patients: a population-based study in schizophrenia","volume":"68","author":"Cooper","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.04.003_bib9","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/JCP.0b013e3182856886","article-title":"Insight and Hostility as Predictors and Correlates of Nonadherence in the European First Episode Schizophrenia Trial","volume":"33","author":"Czobor","year":"2013","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2015.04.003_bib10","series-title":"Abnormal Involuntary Movement Scale (AIMS)","author":"Department of Health, E. and W.","year":"1974"},{"key":"10.1016\/j.euroneuro.2015.04.003_bib11","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.euroneuro.2010.02.001","article-title":"Drug attitude as predictor for effectiveness in first-episode schizophrenia: results of an open randomized trial (EUFEST)","volume":"20","author":"Gaebel","year":"2010","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2015.04.003_bib12","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1600-0447.1993.tb03366.x","article-title":"The St. Hans Rating Scale for extrapyramidal syndromes: reliability and validity","volume":"87","author":"Gerlach","year":"1993","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2015.04.003_bib13","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1600-0447.2007.01087.x","article-title":"Subjective response and attitudes toward antipsychotic drug therapy during the initial treatment period: a prospective follow-up study in patients with schizophrenia","volume":"116","author":"Hofer","year":"2007","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2015.04.003_bib14","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s00406-005-0633-3","article-title":"Correlates of subjective and functional outcomes in outpatient clinic attendees with schizophrenia and schizoaffective disorder","volume":"256","author":"Hofer","year":"2006","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.euroneuro.2015.04.003_bib15","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(08)60486-9","article-title":"Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial","volume":"371","author":"Kahn","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.euroneuro.2015.04.003_bib16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2015.04.003_bib17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/bmj.312.7027.345","article-title":"Compliance therapy in psychotic patients: randomised controlled trial","volume":"312","author":"Kemp","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.euroneuro.2015.04.003_bib18","doi-asserted-by":"crossref","first-page":"892","DOI":"10.4088\/JCP.v63n1007","article-title":"Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature","volume":"63","author":"Lacro","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.04.003_bib19","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.euroneuro.2015.04.003_bib20","doi-asserted-by":"crossref","first-page":"990","DOI":"10.4088\/JCP.08m04221","article-title":"Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior response","volume":"70","author":"Lindenmayer","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.04.003_bib21","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1365-2850.2008.01277.x","article-title":"Risk profiles for non-adherence to antipsychotic medications","volume":"15","author":"McCann","year":"2008","journal-title":"J. Psychiatr. Ment. Health Nurs."},{"key":"10.1016\/j.euroneuro.2015.04.003_bib22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00005053-198901000-00007","article-title":"Insight in schizophrenia. Its relationship to acute psychopathology","volume":"177","author":"McEvoy","year":"1989","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.euroneuro.2015.04.003_bib23","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/schbul\/sbn067","article-title":"Cross-sectional and longitudinal relationships between insight and attitudes toward medication and clinical outcomes in chronic schizophrenia","volume":"35","author":"Mohamed","year":"2009","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2015.04.003_bib24","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.4088\/JCP.v63n1206","article-title":"Predictors of noncompliance in patients with schizophrenia","volume":"63","author":"Perkins","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.04.003_bib25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.schres.2005.10.016","article-title":"Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode","volume":"83","author":"Perkins","year":"2006","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2015.04.003_bib26","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.4088\/JCP.v65n0908","article-title":"Compliance in schizophrenia: psychopathology, side effects, and patients\u2019 attitudes toward the illness and medication","volume":"65","author":"Rettenbacher","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.04.003_bib27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0920-9964(01)00312-7","article-title":"Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder","volume":"57","author":"Robinson","year":"2002","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2015.04.003_bib28","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.euroneuro.2014.07.001","article-title":"Extrapyramidal symptoms during treatment of first schizophrenia episode: results from EUFEST","volume":"24","author":"Rybakowski","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"Suppl. 20","key":"10.1016\/j.euroneuro.2015.04.003_bib29","first-page":"S22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"issue":"Suppl.","key":"10.1016\/j.euroneuro.2015.04.003_bib30","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2015.04.003_bib31","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1176\/ajp.155.2.226","article-title":"Violence and severe mental illness: the effects of substance abuse and nonadherence to medication","volume":"155","author":"Swartz","year":"1998","journal-title":"Am. J. Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.euroneuro.2015.04.003_bib32","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1007\/s001270050213","article-title":"Taking the wrong drugs: the role of substance abuse and medication noncompliance in violence among severely mentally ill individuals","volume":"33","author":"Swartz","year":"1998","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"10.1016\/j.euroneuro.2015.04.003_bib33","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/01.nmd.0000202575.79453.6e","article-title":"Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study","volume":"194","author":"Swartz","year":"2006","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.euroneuro.2015.04.003_bib34","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/0962280206074463","article-title":"Multiple imputation of discrete and continuous data by fully conditional specification","volume":"16","author":"van Buuren","year":"2007","journal-title":"Stat. Methods Med. Res."},{"key":"10.1016\/j.euroneuro.2015.04.003_bib35","series-title":"Flexible Imputation of Missing Data","author":"van Buuren","year":"2012"},{"key":"10.1016\/j.euroneuro.2015.04.003_bib36","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.schres.2013.05.006","article-title":"Drug and alcohol trajectories among adults with schizophrenia: data from the CATIE study","volume":"148","author":"Van Dorn","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2015.04.003_bib37","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/archpsyc.1974.01760130049008","article-title":"Why do schizophrenic patients refuse to take their drugs?","volume":"31","author":"Van Putten","year":"1974","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.04.003_bib38","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1176\/appi.ps.54.5.665","article-title":"Psychopharmacology: perspectives on medication adherence and atypical antipsychotic medications","volume":"54","author":"Velligan","year":"2003","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.euroneuro.2015.04.003_bib39","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1176\/ps.2007.58.9.1187","article-title":"Relationships among subjective and objective measures of adherence to oral antipsychotic medications","volume":"58","author":"Velligan","year":"2007","journal-title":"Psychiatr. Serv."},{"issue":"Suppl. 4","key":"10.1016\/j.euroneuro.2015.04.003_bib40","first-page":"S1","article-title":"The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness","volume":"70","author":"Velligan","year":"2009","journal-title":"J. Clin. Psychiatry"},{"issue":"Suppl. 4","key":"10.1016\/j.euroneuro.2015.04.003_bib41","first-page":"S1","article-title":"The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness","volume":"70","author":"Velligan","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.04.003_bib42","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/01.pra.0000388626.98662.a0","article-title":"Strategies for addressing adherence problems in patients with serious and persistent mental illness: recommendations from the expert consensus guidelines","volume":"16","author":"Velligan","year":"2010","journal-title":"J. Psychiatr. Pract."},{"key":"10.1016\/j.euroneuro.2015.04.003_bib43","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1176\/appi.ps.55.8.886","article-title":"Partial compliance and risk of rehospitalization among California medicaid patients with schizophrenia","volume":"55","author":"Weiden","year":"2004","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.euroneuro.2015.04.003_bib44","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/01.nmd.0000221289.54911.63","article-title":"Substance abuse and the management of medication nonadherence in schizophrenia","volume":"194","author":"Wilk","year":"2006","journal-title":"J. Nerv. Ment. Dis."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X15001030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X15001030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T01:09:01Z","timestamp":1691629741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X15001030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0924977X15001030"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2015.04.003","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment adherence in schizophrenia: A patient-level meta-analysis of combined CATIE and EUFEST studies","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2015.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}